Levetiracetam in Tourette syndrome: A randomized double blind, placebo controlled study

Journal of Pediatric Neurology

Volumn 7, Issue 3, 2009, Pages 257-263

  Awaad, Yasser ^a,b,c   Michon, Anne Marie ^b   Minarik, Sarah ^b   Rizk, Tamer ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Oakwood Healthcare Inc   (United States)

^c KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Adolescents; Children; Levetiracetam; Tics; Tourette syndrome

Indexed keywords

ETIRACETAM; PLACEBO;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; ASTHENIA; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVISED CONNER SCALE; TIC; YALE GLOBAL TIC SEVERITY SCALE;

EID: 67749116288     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: 10.3233/JPN-2009-0300     Document Type: Article

References (14)

1. B.A. Corbett, S.P. Mendoza, C.L. Baym, S.A. Bunge and S. Levine, Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome, Psychoneuroendocrinology 33 (2008), 810-820.
2. T. Spencer, J. Biederman, B. Coffey, D. Geller, S. Faraone, T. Wilens, Tourette disorder and ADHD, Adv Neurol 85 (2001), 57-77.
3. C.G. Goetz, C.M. Tanner, R.S. Wilson, V.S. Carroll, P.G. Como and K.M. Shannon, Clonidine and Gilles de la Tourette's syndrome: Double-blind study using objective rating methods, Ann Neurol 21 (1987), 307-310.
4. J.F. Leckman, M.T. Hardin, M.A. Riddle, J. Stevenson, S.I. Ort and D.J. Cohen, Clonidine treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry 48 (1991), 324-328.
5. R.D. Bruun, Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder, Am J Psychiatry 145 (1988), 621-624.
6. Y. Awaad, Tics in Tourette syndrome: New treatment options, J Child Neurol 14 (1999), 316-319.
7. P.J. Hoekstra, R.B. Minderaa and C.G. Kallenberg, Lack of effect of intravenous immunoglobulins on tics: A double-blind placebo-controlled study, J Clin Psychiatry 65 (2004), 537-542.
8. V.P. Zykov, A.I.U. Shcherbina, E.B. Novikova and T.V. Shvabrina, Neuroimmunological aspects of the pathogenesis of Tourette syndrome and use of immunoglobulins in the treatment of children, Zh Nevrol Psikhiatr Im S S Korsakova 108 (2008), 10-13 (in Russian).
9. Y. Awaad, A.M. Michon and S. Minarik, Long-term use of levetiracetam to treat tics in children and adolescents with Tourette syndrome, J Pediatr Neurol 5 (2007), 209-214.
10. Y. Awaad, A.M. Michon and S. Minarik, Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome, Mov Disord 20 (2005), 714-718.
11. J.M. Rigo, G. Hans, L. Nguyen et al., The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents, Br J Pharmacol 136 (2002), 659-672.
12. B.A. Lynch, N. Lambeng, K. Nocka et al., The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam, Proc Natl Acad Sci USA 101 (2004), 9861-9866.
13. D.G. Margineanu and H. Klitgaard, Levetiracetam, mechanisms of actions, in: Antiepileptic Drugs, (5th ed.), R.H. Levy, R.H. Mattson, B.S. Meldrum and E. Perucca, eds, Philadelphia: Lippincott Williams & Wilkins, 2002, pp. 419-427.
14. I.V. Plotnikova, A.L. Spirina, Y.I. Polyakov et al., Tourette's syndrome: The effect of stereotactic bilateral cingulotomy and anterior capsulotomy, Int J Psychophysiol 69 (2008), 267.